Cover Image
Market Research Report
Product code 
1063211

Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2026

Published: | MarketsandMarkets | 212 Pages | Delivery time: 1-2 business days

Price

Back to Top
Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2026
Published: February 28, 2022
MarketsandMarkets
Content info: 212 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The global organ preservation market is projected to reach USD 317 million by 2026 from USD 270 million in 2021, at a CAGR of 6.6%. Growth in this market is majorly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations.

However, concerns related to the high cost of organ transplantations and religious concerns in specific geographies are expected to limit the growth of this market to a certain extent.

"The University of Wisconsin (UW) holds the largest market share in the solution market."

Based on the Solution, the segment is divided into UW, Custodial HTK, Perfadex and Other solutions (EuroCollins and Celsior). In 2020, the UW solution accounted for the largest share of the market. The UW solution is used for the flushing and storage of kidneys, liver, and pancreas. It was the first intracellular preservation medium, considered the gold standard for organ preservation.

"Normothermic Machine Perfusion is expected to register the highest CAGR in the forecast period."

Normothermic machine perfusion marked the highest CAGR in the forecast period of 2021 to 2026. Normothermic perfusion is a technique that recreates the physiologic environment by maintaining average organ temperature and providing essential substrates for cellular metabolism, oxygenation, and nutrition. It is said to enhance the safety and efficacy of the organ and improve repair before transplantation. The normothermic technique is said to reduce the pro-inflammatory response in the liver and the risk of ischemic injuries while promoting graft regeneration. The possibility of long-term graft survival and reduced delayed graft functioning in organs of marginal quality (such as those from older donors) has made normothermic machine perfusion increasingly relevant.

Static cold storage and hypothermic machine perfusion are the other techniques involved in this segment.

"Kidneys hold the largest share in the market, by organ type."

Kidneys accounts for a market share in the organ segment. Renal transplantation is considered the treatment of choice for patients with end-stage renal disease (ESRD) or kidney failure, diabetes, etc. are all cause for the growth of this segment. Other causes of ESRD in adult patients are polycystic kidney disease and glomerulonephritis. With the rising incidence of diabetes, the number of patients with ESRD or kidney failure is expected to increase, which will drive demand for kidney transplants. Moreover, improvements in graft survival and long-term graft function have made kidney transplantation a cost-effective alternative to dialysis. Major organs like Lungs, Liver, Kidney and Heart are a part of this segment.

"Transplant centers hold the largest share in the market, by end user."

Based on end users, the organ preservation market is segmented into organ transplant centers, hospitals, and specialty clinics. In 2020, the organ transplant centers segment accounted for the largest share of the organ preservation market. The increasing number of transplant centers across the globe is the key factor driving the acceptance of this end-user segment and propelling the market growth.

"The Asia Pacific to witness the highest growth during the forecast period."

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2021-2026. The major factors driving the growth of the Asia Pacific market include favorable government initiatives, increased awareness in people and increased organ donations. Intensified public education, mobilization, and advancements in organ transplant technologies have improved the donation rate in China. In India, rapid improvements in the country's healthcare infrastructure have supported market growth while encouraging medical tourism. The willingness to donate organs in Japan has led to the improvement in organ donation despite religious issues.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
  • By Designation - C-level-35%, Director-level-25%, Others-40%
  • By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%

Key players in the Organ Preservation Market

The key players operating in the organ preservation market include: Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Kohler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), and TX Innovations (Netherlands).

Research Coverage:

The report analyzes the organ preservation market and aims at estimating the market size and future growth potential of this market based on various segments such as solution, technique, organ type, end user, and region. The report also includes a product portfolio matrix of various organ preservation products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global organ preservation market. The report analyzes this market by solution, technique, organ type, and end user.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global organ preservation market
  • Market Development: Comprehensive information on the lucrative emerging markets by solution, technique, organ type and end user
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global organ preservation market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global organ preservation market.
Product Code: MD 4464

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKET SEGMENTATION
    • FIGURE 1 ORGAN PRESERVATION MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
    • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.4 STAKEHOLDERS
  • 1.5 LIMITATIONS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • FIGURE 2 ORGAN PRESERVATION MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Insights from primary experts
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION: ORGAN PRESERVATION MARKET
    • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • FIGURE 7 ILLUSTRATIVE EXAMPLE OF PROCEDURE-BASED MARKET ESTIMATION
    • FIGURE 8 TOP-DOWN APPROACH
    • FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ORGAN PRESERVATION MARKET (2021-2026)
    • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET RANKING ANALYSIS
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: ORGAN PRESERVATION MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 12 ORGAN PRESERVATION MARKET, BY SOLUTION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 ORGAN PRESERVATION MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 GEOGRAPHIC ANALYSIS: ORGAN PRESERVATION MARKET

4 PREMIUM INSIGHTS

  • 4.1 ORGAN PRESERVATION MARKET OVERVIEW
    • FIGURE 17 RISING NUMBER OF SOLID ORGAN TRANSPLANTS TO DRIVE GROWTH IN THE GLOBAL ORGAN PRESERVATION MARKET
  • 4.2 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION & COUNTRY
    • FIGURE 18 THE UNIVERSITY OF WISCONSIN SOLUTION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC ORGAN PRESERVATION SOLUTIONS MARKET IN 2020
  • 4.3 ORGAN PRESERVATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 CHINA IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • 4.4 ORGAN PRESERVATION MARKET, BY REGION (2019-2026)
    • FIGURE 20 NORTH AMERICA TO DOMINATE THE ORGAN PRESERVATION MARKET TILL 2026
  • 4.5 ORGAN PRESERVATION MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • TABLE 3 MARKET DYNAMICS: ORGAN PRESERVATION MARKET
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing geriatric population and subsequent growth in cases of multiple organ failure
    • TABLE 4 GROWTH IN GERIATRIC POPULATION (ABOVE-65 AGE GROUP), BY REGION, 2019 VS. 2050 (MILLION)
      • 5.2.1.2 Increasing initiatives to promote public awareness and encourage organ donation
      • 5.2.1.3 Rising number of organ donors and growing adoption of solid organ transplantation procedures
    • TABLE 5 NUMBER OF ORGAN DONATIONS, 2020
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of organ transplantation
      • 5.2.2.2 Religious concerns and misconceptions associated with organ donation
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing healthcare investments
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Significant gap between the number of organs donated and organs required annually
      • 5.2.4.2 Development of artificial organs
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 SINGLE-PORT ROBOT-ASSISTED KIDNEY TRANSPLANT
    • 5.3.2 PIG-TO-HUMAN XENOTRANSPLANTATION
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 6 PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT FROM NEW ENTRANTS
    • 5.4.2 THREAT FROM SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF SUPPLIERS
    • 5.4.4 BARGAINING POWER OF BUYERS
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 PRICING ANALYSIS
    • TABLE 7 AVERAGE SELLING PRICE OF ORGAN PRESERVATION BY SOLUTION AND BY ORGANS
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 22 ORGAN PRESERVATION MARKET: ECOSYSTEM ANALYSIS
  • 5.7 VALUE CHAIN ANALYSIS
    • FIGURE 23 ORGAN PRESERVATION MARKET: VALUE CHAIN ANALYSIS
  • 5.8 PATENT ANALYSIS
    • 5.8.1 PATENT PUBLICATION TRENDS FOR ORGAN PRESERVATION
    • FIGURE 24 PATENT PUBLICATION TRENDS (2011-2022)
    • 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ORGAN PRESERVATION PATENTS (JANUARY 2011-FEBRUARY 2022)
    • FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR ORGAN PRESERVATION PATENTS (JANUARY 2011-FEBRUARY 2022)
    • TABLE 8 LIST OF PATENTS/PATENT APPLICATIONS IN THE ORGAN PRESERVATION MARKET, 2020-2021
  • 5.9 REGULATORY LANDSCAPE
    • 5.9.1 NORTH AMERICA
      • 5.9.1.1 US
      • 5.9.1.2 Canada
    • 5.9.2 EUROPE
    • 5.9.3 ASIA PACIFIC
  • 5.10 IMPACT OF COVID-19 ON THE ORGAN PRESERVATION MARKET

6 ORGAN PRESERVATION MARKET, BY SOLUTION

  • 6.1 INTRODUCTION
    • TABLE 9 ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 10 ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.2 UNIVERSITY OF WISCONSIN
    • 6.2.1 UW SOLUTIONS COMPRISE METABOLICALLY INERT SUBSTRATES, WHICH ENABLE BETTER TRANSPLANTATION OUTCOMES-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 11 ORGAN PRESERVATION MARKET FOR UW SOLUTIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.3 CUSTODIOL HTK
    • 6.3.1 DESPITE ITS LOW COST AND EASY DIFFUSION, THE DEMAND FOR HTK HAS DECLINED IN RECENT YEARS-A KEY FACTOR LIMITING MARKET GROWTH
    • TABLE 12 ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK SOLUTIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.4 PERFADEX
    • 6.4.1 LAUNCH OF PERFADEX PLUS TO DRIVE MARKET GROWTH
    • TABLE 13 ORGAN PRESERVATION MARKET FOR PERFADEX SOLUTIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.5 OTHER SOLUTIONS
    • TABLE 14 OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

7 ORGAN PRESERVATION MARKET, BY TECHNIQUE

  • 7.1 INTRODUCTION
    • TABLE 15 COMPARISON OF THE METHODS USED FOR ORGAN PRESERVATION
    • TABLE 16 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 17 ORGAN PRESERVATION TECHNIQUES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.2 STATIC COLD STORAGE
    • 7.2.1 STATIC COLD STORAGE IS THE MOST WIDELY ADOPTED METHOD- A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 18 STATIC COLD STORAGE: ADVANTAGES & DISADVANTAGES
    • TABLE 19 ORGAN PRESERVATION MARKET FOR STATIC COLD STORAGE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 HYPOTHERMIC MACHINE PERFUSION
    • 7.3.1 ADVANTAGES ASSOCIATED WITH HYPOTHERMIC MACHINE PERFUSION, SUCH AS ENHANCED ORGAN PRESERVATION QUALITY AND SURVIVAL RATE, TO DRIVE MARKET GROWTH
    • TABLE 20 HYPOTHERMIC MACHINE PERFUSION: ADVANTAGES & DISADVANTAGES
    • TABLE 21 ORGAN PRESERVATION MARKET FOR HYPOTHERMIC MACHINE PERFUSION, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 NORMOTHERMIC MACHINE PERFUSION
    • 7.4.1 TECHNOLOGICAL DEVELOPMENTS AND ADVANTAGES OF NORMOTHERMIC MACHINE PERFUSION TO DRIVE MARKET GROWTH
    • TABLE 22 NORMOTHERMIC MACHINE PERFUSION: ADVANTAGES & DISADVANTAGES
    • TABLE 23 ORGAN PRESERVATION MARKET FOR NORMOTHERMIC MACHINE PERFUSION, BY COUNTRY, 2019-2026 (USD MILLION)

8 ORGAN PRESERVATION MARKET, BY ORGAN TYPE

  • 8.1 INTRODUCTION
    • FIGURE 27 NUMBER OF ORGAN TRANSPLANTS GLOBALLY, 2020
    • TABLE 24 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
  • 8.2 KIDNEYS
    • 8.2.1 KIDNEYS ARE THE MOST TRANSPLANTED ORGANS GLOBALLY-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 25 NUMBER OF KIDNEY TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
    • TABLE 26 TOTAL KIDNEY TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
    • FIGURE 28 US: NUMBER OF ESRD PATIENTS ADDED TO THE WAITING LIST FOR KIDNEY TRANSPLANTS, 2000-2018
    • FIGURE 29 US: COUNT AND RATE OF KIDNEY TRANSPLANTS IN PATIENTS UNDERGOING DIALYSIS, 2000-2018
    • TABLE 27 KIDNEY PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 LIVER
    • 8.3.1 RISING PREVALENCE OF LIVER DISEASE AND GROWING CASES OF LIVER FAILURE TO DRIVE THE DEMAND FOR LIVER TRANSPLANTATION PROCEDURES
    • TABLE 28 NUMBER OF LIVER TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
    • TABLE 29 TOTAL LIVER TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
    • TABLE 30 LIVER PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 LUNGS
    • 8.4.1 GROWTH IN COPD INCIDENCE BOOSTS THE DEMAND FOR PRESERVATION TECHNIQUES AND PRODUCTS
    • TABLE 31 US: PREVALENCE OF COPD CASES IN MAJOR STATES, BY GENDER, 2018
    • TABLE 32 NUMBER OF LUNG TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
    • TABLE 33 TOTAL LUNG TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
    • TABLE 34 LUNG PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 HEART
    • 8.5.1 ADVANCEMENTS IN HEART PRESERVATION TECHNIQUES TO DRIVE MARKET GROWTH
    • TABLE 35 NUMBER OF HEART TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
    • TABLE 36 TOTAL HEART TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
    • TABLE 37 HEART PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.6 PANCREAS
    • 8.6.1 GROWING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH
    • TABLE 38 NUMBER OF PANCREAS TRANSPLANTS IN MAJOR COUNTRIES, 2017-2020
    • TABLE 39 TOTAL PANCREAS TRANSPLANT CENTERS IN MAJOR COUNTRIES, 2019 VS. 2020
    • TABLE 40 PANCREAS PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

9 ORGAN PRESERVATION MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 41 ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 ORGAN TRANSPLANT CENTERS
    • 9.2.1 ORGAN TRANSPLANT CENTERS ARE THE MAJOR END USERS OF ORGAN PRESERVATION SOLUTIONS
    • FIGURE 30 NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 42 ORGAN PRESERVATION MARKET FOR ORGAN TRANSPLANT CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 HOSPITALS
    • 9.3.1 INCREASING INCIDENCE OF ACCIDENTAL INJURIES AND CHRONIC DISEASES TO DRIVE MARKET GROWTH
    • TABLE 43 ORGAN PRESERVATION MARKET FOR HOSPITALS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.4 SPECIALTY CLINICS
    • 9.4.1 INCREASING PREVALENCE OF END-STAGE DISEASES AND ORGAN FAILURE TO DRIVE MARKET GROWTH
    • TABLE 44 ORGAN PRESERVATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)

10 ORGAN PRESERVATION MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 31 CHINA IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE ORGAN PRESERVATION MARKET
    • FIGURE 32 TOTAL NUMBER OF ORGAN TRANSPLANTS IN SOME COUNTRIES, 2019 VS. 2020
    • TABLE 45 ORGAN PRESERVATION MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 33 NORTH AMERICA: ORGAN PRESERVATION MARKET SNAPSHOT
    • TABLE 46 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 47 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 48 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 49 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 50 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Growing cases of organ failure and underlining diseases to drive the demand for organ transplantation in the US
    • TABLE 51 NUMBER OF ORGAN TRANSPLANTS IN THE US, 2017-2020
    • TABLE 52 WAITING LIST FOR ORGAN TRANSPLANTS (AS OF JANUARY 2022)
    • FIGURE 34 US: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 53 US: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 54 US: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 55 US: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 US: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Improved organ donation rates to drive growth in the market in Canada
    • TABLE 57 CANADA: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • FIGURE 35 CANADA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020
    • TABLE 58 ACTIVE WAITING LIST FOR ORGAN TRANSPLANTS, 2019
    • TABLE 59 CANADA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 60 CANADA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 61 CANADA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 62 CANADA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 63 EUROPE: ORGAN PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 64 EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 65 EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 66 EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 67 EUROPE: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 FRANCE
      • 10.3.1.1 Increasing number of organ transplants and organ donor registrations promote future growth of the organ preservation market in France
    • TABLE 68 FRANCE: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • FIGURE 36 FRANCE: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 69 FRANCE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 70 FRANCE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 71 FRANCE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 72 FRANCE: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.2 SPAIN
      • 10.3.2.1 Spain registered the second-highest deceased organ donation rate globally-a key factor driving market growth
    • TABLE 73 SPAIN: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • TABLE 74 SPAIN: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST, 2017-2019
    • FIGURE 37 SPAIN: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020
    • TABLE 75 SPAIN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 76 SPAIN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 77 SPAIN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 78 SPAIN: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Growth in the market in the UK is mainly driven by the increasing disease/disorder prevalence and favorable regulations
    • TABLE 79 UK: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • TABLE 80 UK: TOTAL NUMBER OF PATIENTS ON THE ACTIVE ORGAN TRANSPLANT WAITING LIST (AS OF APRIL 8, 2021)
    • FIGURE 38 UK: NUMBER OF ORGAN TRANSPLANT CENTERS, 2020
    • TABLE 81 UK: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 82 UK: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 83 UK: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 UK: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Declining rate of organ donation and transplant due to COVID-19 limited market growth in 2020
    • TABLE 85 ITALY: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • TABLE 86 ITALY: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST, 2020
    • FIGURE 39 ITALY: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 87 ITALY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 88 ITALY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 89 ITALY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 90 ITALY: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.5 GERMANY
      • 10.3.5.1 Low organ donation and transplant rates form a major concern for the German market
    • TABLE 91 GERMANY: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • TABLE 92 GERMANY: TOTAL NUMBER OF PATIENTS ACTIVE ON THE ORGAN TRANSPLANT WAITING LIST, 2019-2021
    • FIGURE 40 GERMANY: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 93 GERMANY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 94 GERMANY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 95 GERMANY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 GERMANY: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 97 ROE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 98 ROE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 99 ROE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 ROE: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 41 ASIA PACIFIC: ORGAN PRESERVATION MARKET SNAPSHOT
    • TABLE 101 APAC: ORGAN PRESERVATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 102 APAC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 103 APAC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 104 APAC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 APAC: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Growing awareness and adoption of laws favoring organ donation to drive market growth in China
    • TABLE 106 CHINA: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • FIGURE 42 CHINA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 107 CHINA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 108 CHINA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 109 CHINA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 CHINA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.2 INDIA
      • 10.4.2.1 Lack of awareness is a key barrier to market growth in India
    • FIGURE 43 INDIA: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 111 INDIA: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • TABLE 112 INDIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 113 INDIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 114 INDIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 115 INDIA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Religious beliefs and lack of awareness limit market growth in Japan
    • TABLE 116 JAPAN: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • TABLE 117 JAPAN: TOTAL NUMBER OF PATIENTS ON THE ORGAN TRANSPLANT WAITING LIST (AS OF MARCH 31, 2021)
    • FIGURE 44 JAPAN: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 118 JAPAN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 119 JAPAN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 120 JAPAN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 121 JAPAN: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 122 ROAPAC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 123 ROAPAC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 124 ROAPAC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 ROAPAC: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 IMPLEMENTATION OF EDUCATIONAL PROGRAMS TO TRAIN PROFESSIONALS ON ORGAN RETRIEVAL AND TRANSPLANT PROCEDURES TO DRIVE MARKET GROWTH
    • TABLE 126 BRAZIL: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • FIGURE 45 BRAZIL: NUMBER OF ORGAN TRANSPLANT CENTERS, 2019 VS. 2020
    • TABLE 127 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 128 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 129 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 IMPLEMENTATION OF GOVERNMENT INITIATIVES AND POLICIES TO DRIVE MARKET GROWTH
    • TABLE 131 SAUDI ARABIA: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • TABLE 132 ISRAEL: NUMBER OF ORGAN TRANSPLANTS, 2017-2020
    • TABLE 133 UAE: NUMBER OF ORGAN TRANSPLANTS, 2018-2020
    • TABLE 134 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019-2026 (USD MILLION)
    • TABLE 135 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2019-2026 (USD MILLION)
    • TABLE 136 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019-2026 (USD MILLION)
    • TABLE 137 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE ORGAN PRESERVATION MARKET
  • 11.3 MARKET RANKING ANALYSIS
    • TABLE 138 ORGAN PRESERVATION MARKET RANKING ANALYSIS, BY KEY PLAYER, 2020
  • 11.4 COMPETITIVE BENCHMARKING
    • 11.4.1 FOOTPRINT OF COMPANIES IN THE ORGAN PRESERVATION MARKET
    • TABLE 139 COMPANY ORGAN PRESERVATION SOLUTION & DEVICE FOOTPRINT
    • TABLE 140 COMPANY TECHNIQUE FOOTPRINT
    • TABLE 141 COMPANY REGIONAL FOOTPRINT
  • 11.5 COMPETITIVE LEADERSHIP MAPPING
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 46 ORGAN PRESERVATION MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
  • 11.6 COMPETITIVE SCENARIO
    • 11.6.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 142 PRODUCT LAUNCHES & APPROVALS, 2018-2022
    • 11.6.2 DEALS
    • TABLE 143 DEALS, 2018-2022
    • 11.6.3 OTHER DEVELOPMENTS
    • TABLE 144 OTHER DEVELOPMENTS, 2018-2022

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 PARAGONIX TECHNOLOGIES, INC.
    • TABLE 145 PARAGONIX TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • 12.1.2 XVIVO PERFUSION AB
    • TABLE 146 XVIVO PERFUSION AB: BUSINESS OVERVIEW
    • FIGURE 47 XVIVO PERFUSION AB: COMPANY SNAPSHOT (2020)
    • 12.1.3 DR. FRANZ KOHLER CHEMIE GMBH
    • TABLE 147 DR. FRANZ KOHLER CHEMIE GMBH: BUSINESS OVERVIEW
    • 12.1.4 ESSENTIAL PHARMACEUTICALS, LLC (A SUBSIDIARY OF ACCORD HEALTHCARE)
    • TABLE 148 ESSENTIAL PHARMACEUTICALS, LLC: BUSINESS OVERVIEW
    • 12.1.5 TRANSMEDICS, INC.
    • TABLE 149 TRANSMEDICS, INC.: BUSINESS OVERVIEW
    • 12.1.6 ORGANOX LIMITED
    • TABLE 150 ORGANOX LIMITED: BUSINESS OVERVIEW
    • 12.1.7 21ST CENTURY MEDICINE
    • TABLE 151 21ST CENTURY MEDICINE: BUSINESS OVERVIEW
    • 12.1.8 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
    • TABLE 152 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
    • 12.1.9 BRIDGE TO LIFE LIMITED
    • TABLE 153 BRIDGE TO LIFE LIMITED: BUSINESS OVERVIEW
    • 12.1.10 WATERS MEDICAL SYSTEMS LLC
    • TABLE 154 WATERS MEDICAL SYSTEMS: BUSINESS OVERVIEW
    • 12.1.11 PRESERVATION SOLUTIONS, INC.
    • TABLE 155 PRESERVATION SOLUTIONS, INC.: BUSINESS OVERVIEW
    • 12.1.12 CARNAMEDICA
    • TABLE 156 CARNAMEDICA: BUSINESS OVERVIEW
    • 12.1.13 TRANSPLANT BIOMEDICALS
    • TABLE 157 TRANSPLANT BIOMEDICALS: BUSINESS OVERVIEW
    • 12.1.14 INSTITUT GEORGES LOPEZ
    • TABLE 158 INSTITUT GEORGES LOPEZ: BUSINESS OVERVIEW
    • 12.1.15 GLOBAL TRANSPLANT SOLUTIONS
    • TABLE 159 GLOBAL TRANSPLANT SOLUTIONS: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 AVIONORD
    • TABLE 160 AVIONORD: BUSINESS OVERVIEW
    • 12.2.2 ORGAN PRESERVATION SOLUTIONS LTD.
    • TABLE 161 ORGAN PRESERVATION SOLUTIONS LTD.: BUSINESS OVERVIEW
    • 12.2.3 EBERS
    • TABLE 162 EBERS: BUSINESS OVERVIEW
    • 12.2.4 S.A.L.F.
    • TABLE 163 S.A.L.F.: BUSINESS OVERVIEW
    • 12.2.5 BIOCHEFA
    • TABLE 164 BIOCHEFA: BUSINESS OVERVIEW
    • 12.2.6 VASCULAR PERFUSION SOLUTIONS, INC.
    • TABLE 165 VASCULAR PERFUSION SOLUTIONS, INC.: BUSINESS OVERVIEW
    • 12.2.7 TX INNOVATIONS
    • TABLE 166 TX INNOVATIONS: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS